Sarah Bearer, M.D.
NPI 1760917090 · Endocrinology, Diabetes & Metabolism Physician · Midlothian, VA
Enrolled with Medicare as Practitioner - Endocrinology · source: CMS PECOS Public Provider Enrollment (2026.04.01)
Provider details
- NPI number
- 1760917090
- Entity type
- Individual
- Primary specialty
- Endocrinology, Diabetes & Metabolism PhysicianAllopathic & Osteopathic Physicians
- Credential
- M.D.
- Sex
- Female
- Sole proprietor
- No
- License
- 0101275221 (VA)
Specialties & taxonomies
Allopathic & Osteopathic Physicians
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure28% of score
9 yrs in NPPES registry
- Profile completeness28% of score
100% of core fields populated
- Practice footprint17% of score
1 documented practice location
- Medicare service volume (vs. specialty peers)28% of score
2,358 Medicare services, 2024 (ranked within specialty)
Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our methodology.
What this provider does (Medicare)
Based on Medicare fee-for-service claims, 2024; not all care is captured.
| Service (HCPCS) | Medicare services | Typical Medicare-allowed (2024) |
|---|---|---|
| Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More99214 | 450 | $128 |
| Blood Test, Comprehensive Group of Blood Chemicals80053 | 239 | $10 |
| Complete Blood Cell Count (red Cells, White Blood Cell, Platelets), Automated Test85027 | 178 | $6 |
| Hemoglobin A1c Level83036 | 174 | $9 |
| Blood Test, Thyroid Stimulating Hormone (tsh)84443 | 163 | $16 |
| Blood Test, Lipids (cholesterol and Triglycerides)80061 | 162 | $13 |
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 37 distinct drugs on file.
| Drug | Part D claims (2024) | Beneficiaries |
|---|---|---|
| Levothyroxine Sodium | 220 | 72 |
| Semaglutidebrand: Ozempic | 194 | 52 |
| Empagliflozinbrand: Jardiance | 130 | 38 |
| Metformin Hclbrand: Metformin Hcl Er | 128 | 50 |
| Tirzepatidebrand: Mounjaro | 123 | 31 |
| Rosuvastatin Calcium | 110 |
Practice location
Mailing address
Registry dates
- Enumerated
- 2017-04-24
- Last updated
- 2024-07-24
- Certified
- 2024-07-24
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.